Therapix Biosciences Ltd.
TRPX
TRPX was delisted on the 1st of July, 2020.
4 hedge funds and large institutions have $11K invested in Therapix Biosciences Ltd. in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
45% less capital invested
Capital invested by funds: $20K → $11K (-$9K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.77K |
| 2 |
Morgan Stanley
New York
|
+$5.69K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $5K | +$5.69K | +10,030 | +667% |
|
|
2
Citadel Advisors
Miami,
Florida
| $4K | +$5.77K | +10,180 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | +$2.03K | +3,576 | +189% |
|
|
ARTA
4
A.R.T. Advisors
New York
| – | -$15K | -13,504 | Closed |
|
TRPX Hedge Fund Activity: Q1 2020 in Review
4 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Therapix Biosciences Ltd. (TRPX) for Q1 2020, worth a combined $11K — down 45% from $20K a quarter earlier.
Fund positioning in TRPX was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $5.77K. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $15K sold.
- 4 institutional investors held Therapix Biosciences Ltd. (TRPX) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $11K of Therapix Biosciences Ltd. stock for Q1 2020, down 45% quarter-over-quarter.
- 1 fund opened new Therapix Biosciences Ltd. positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest Therapix Biosciences Ltd. buyer in Q1 2020 was Citadel Advisors, an estimated $5.77K added.
- The largest Therapix Biosciences Ltd. seller in Q1 2020 was A.R.T. Advisors, an estimated $15K sold.
Based on aggregated 13F filings for Q1 2020.